Abstract:Culture, Immunotherapy, Mesenchymal Stromal Cells (MSCs), Gene Editing, Bioreactor Systems, Regenerative Medicine Cell therapy is revolutionizing modern medicine by offering innovative approaches to treating diseases that were previously considered incurable, such as cancer, organ failure, and degenerative conditions. This editorial summarizes key insights and findings from recent research that explores diverse cell types, innovative induction methods, and advanced culture techniques, all of which drive forward the potential of cell-based therapies. In regenerative medicine, 3D organoid cultures have emerged as a powerful tool for modeling complex tissue structures and functions. The ability to create organoids that mimic human tissues not only improves cell functionality but also provides a valuable platform for disease modeling and drug testing. These advancements in 3D culture techniques are pushing the boundaries of what is possible in cell therapy, offering more realistic models for studying disease mechanisms and developing new therapies (1).Despite the significant progress in cell therapy, several challenges remain. Issues such as off-target effects, the scalability of cell production, and the long-term efficacy of therapies continue to limit their widespread clinical adoption. However, innovations in bioprocessing, gene editing, and culture techniques are steadily addressing these obstacles. The future of cell therapy lies in interdisciplinary collaboration between biologists, engineers, and clinicians. By integrating advanced bioprocessing techniques, optimizing cell delivery methods, and refining immune-modulating therapies, researchers are moving closer to offering accessible, effective, and scalable cellbased treatments. As demonstrated by the research presented in this editorial, the potential for cell therapy to revolutionize healthcare is immense. The next step is ensuring that these therapies reach the patients who need them most.Cell therapy holds transformative potential across a wide range of medical fields, from cancer immunotherapy to regenerative medicine. The integration of innovative cell types, advanced induction methods, and scalable culture techniques is paving the way for the next generation of cell-based therapies. As research in this field continues to evolve, so too does the promise of developing personalized, effective, and safe treatments for a wide array of diseases.

Single-cell transfection technologies for cell therapies and gene editing

A multiplexed microfluidic continuous-flow electroporation system for efficient cell transfection

High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing

Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing

Commercial Scale Manufacturing of Allogeneic Cell Therapy

Exploiting Single-Cell Tools in Gene and Cell Therapy

An Integrated Approach toward the Biomanufacturing of Engineered Cell Therapy Products in a Stirred-Suspension Bioreactor

Accelerating Diverse Cell-Based Therapies Through Scalable Design

Cell-based therapy technology classifications and translational challenges

Editorial: Unlocking the potential of cell therapy: exploring cell types, induction methods, and culture techniques

An efficient low cost means of biophysical gene transfection in primary cells

Microfluidic Devices as Process Development Tools for Cellular Therapy Manufacturing

Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)

Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies

Scaling of cell and gene therapies to population

Automating CAR-T Transfection with Micro and Nano-Technologies

Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics

Design of experiments as a decision tool for cell therapy manufacturing

Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets

From unique challenges to inspired solutions: how vector engineering makes in vivo gene therapy possible

Single-cell Technology in Stem Cell Research